DCI — what changed in the latest 10-Q
A section-by-section comparison of DCI's newest periodic SEC filing (10-K/10-Q) against the prior same-form filing: paragraphs added and removed per section, with verbatim excerpts. Purely a deterministic text diff — no similarity scores, no directional read, not investment advice.
Comparing 10-Q · 2026-06-02 vs the prior 10-Q · 2026-02-26
| Section | Outcome | Added | Removed | Minor | Unchanged |
|---|---|---|---|---|---|
| MD&A | Text added/removed | +27 | −24 | ~39 | 28 |
| Market risk (Item 3) | Text added/removed | 0 | 0 | ~6 | 6 |
| Controls & procedures | Text added/removed | 0 | 0 | ~1 | 1 |
| Legal proceedings | No paragraph-level changes | 0 | 0 | 0 | 1 |
| Risk factors | No paragraph-level changes | 0 | 0 | 0 | 5 |
| Other information | Text added/removed | 0 | 0 | ~1 | 0 |
Counts are paragraphs; added/removed means text added or removed vs the prior filing — no direction or judgement implied.
Representative excerpts
Up to 5 excerpts of about 300 characters per section, quoted verbatim from the two SEC filings.
MD&A
Text added vs the prior filing · source: 10-Q · 2026-06-02
On February 28, 2026, the United States and Israel began a military operation targeting Iranian nuclear sites, military infrastructure, and top leadership. Iran has retaliated with attacks on infrastructure assets and United States and Israeli military bases in the Middle East, as well as a blockade…
Three months ended April 30, 2026 compared with three months ended April 30, 2025
The three months ended April 30, 2025 included a loss on impairment of intangible assets of $62.0 million, or 6.6% of net sales. There was no loss on impairment of intangible assets for the three months ended April 30, 2026. The fiscal 2025 impairment expense included $46.6 million related to Univer…
The three months ended April 30, 2025 included a gain on sale of fixed assets of $1.2 million, or 0.1% of net sales. The gain on sale of fixed assets was driven by the sale of land and a building associated with footprint optimization initiatives in the prior year. There was no gain on the sale of f…
Research and development expenses for the three months ended April 30, 2026 were $19.2 million, or 2.0% of net sales, compared with $21.4 million, or 2.3% of net sales, for the three months ended April 30, 2025, a decrease of $2.2 million, or 10.2%, driven by focused project prioritization.
Text removed vs the prior filing · source: 10-Q · 2026-02-26
Three months ended January 31, 2026 compared with three months ended January 31, 2025
Research and development expenses for the three months ended January 31, 2026 were $18.6 million, or 2.2% of net sales, compared with $21.2 million, or 2.4% of net sales, for the three months ended January 31, 2025, a decrease of $2.6 million, or 11.7%, driven by focused project prioritization.
Interest expense for the three months ended January 31, 2026 was $7.7 million, compared with $5.9 million for the three months ended January 31, 2025, an increase of $1.8 million, or 29.0%. The increase reflected a combination of higher proportion of variable interest rate debt and higher overall le…
Other income, net for the three months ended January 31, 2026 was $5.6 million, compared with other income, net of $5.4 million for the three months ended January 31, 2025, an increase of $0.2 million, which was relatively consistent with the prior year.
The effective tax rate was 20.7% and 23.2% for the three months ended January 31, 2026 and 2025, respectively. The lower effective tax rate was primarily due to an increase in excess tax benefits on stock-based compensation.
How to read Risk Factors (Item 1A) in a 10-Q
A 10-Q risk-factor section usually takes one of three forms; this page classifies it as one of:
- Pointer — the filer states there have been no material changes and points back to the annual 10-K risk factors; there is no own risk text to compare this quarter.
- Partial update — the filer carves out specific updated risks ("except as set forth below"); the excerpts show exactly what is new this quarter.
- Restated in full — the quarter carries the complete risk-factor text. When the prior quarter was only a pointer there is no prior full text to diff against, so the page flags the section as restated instead.
This describes the filing structure only — it is never a judgement on whether risk went up or down.
Source: text-level diff of the two SEC EDGAR filings · deterministic (no AI-generated content) · for reference only · not investment advice